Curis’s stock rises as analysts see ‘the next Pharmacyclics’
November 17, 2023 at 09:04 AM EST
Shares of Curis rose premarket Friday as analysts see biotech company as potential take-out target
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|